Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

    Develop new screening methods and treatments for newborns with potentially fatal or disabling disorders identified through newborn screening, focusing on high priority genetic conditions with potential for future screening.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

    Research grant to develop and test new psychosocial interventions for mental disorders, with focus on experimental therapeutics to translate basic science into treatments.

    HHS-NIH11Due Feb 17, 2027

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

    This grant supports developing and testing innovative psychosocial interventions for mental disorders to accelerate translating research into therapies.

    HHS-NIH11Due Feb 17, 2027

    Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

    Funding available for preclinical studies in rare diseases to show effectiveness of proposed treatments for potential further development into clinical trials.

    HHS-NIH11Due Jun 2, 2027$275,000

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

    Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.

    HHS-NIH11Due Feb 18, 2027$750,000

    Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

    This grant will fund research to improve clinical trial readiness for rare diseases by developing tools like biomarkers and outcome measures to help move new treatments or diagnostics toward successful trials.

    HHS-NIH11Due Feb 17, 2027$275,000